Opinion
Video
An Overview to Myelofibrosis and Disease Risk
Author(s):
Panelists discuss myelofibrosis (MF) and its diagnostic workup, including how patients with primary MF present, the criteria required for diagnosis, and any additional biomarkers or criteria examined in practice.
Video content above is prompted by the following:
- What outstanding updates in PV from ASH 2024 are noteworthy?
- What do you see for the future of PV treatment?
- What are the greatest unmet needs?
- How are ongoing investigational therapies helping to address these unmet needs?
- What clinical pearls can you share for community oncologists?
Related Videos
Related Content
